U.S. to Phase Out PEPFAR Funding in South Africa: Concerns Grow Over Future HIV Response

The United States has announced plans to phase South Africa out of the President's Emergency Plan for AIDS Relief (PEPFAR), ending more than two decades of financial support for one of the world's largest HIV treatment and prevention programmes. The decision, reportedly linked to political disagreements rather than public health considerations, has raised concerns among global health experts about the future of HIV services in the country with the world's largest HIV epidemic.

A Turning Point for a Landmark Global Health Programme

Since its launch in 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has become one of the largest international public health initiatives ever implemented. Created to combat the global HIV/AIDS epidemic, the programme has invested more than US$100 billion worldwide and is widely credited with saving millions of lives through expanded access to antiretroviral therapy, prevention programmes, laboratory services and healthcare workforce development.

South Africa has been one of PEPFAR's largest partner countries, benefiting from extensive support for HIV prevention, diagnosis and treatment over the past two decades.

Political Tensions Behind the Decision

According to a statement issued by the U.S. State Department, South Africa will gradually be removed from PEPFAR because it has allegedly failed to make progress on a number of policy requests made by the U.S. administration.

Although the statement does not explicitly list these requirements, previous discussions between the two governments have centred on issues including South Africa's land reform legislation, Black Economic Empowerment policies and the country's foreign policy positions.

Importantly, the announced withdrawal is not linked to the performance or effectiveness of HIV programmes themselves but appears to be part of broader diplomatic and political disputes.

What Could This Mean for South Africa's HIV Response?

South Africa carries the largest HIV burden worldwide, with approximately 8 million people living with HIV. Although the country finances a substantial proportion of its own HIV programme, international support continues to play an important role in prevention, community outreach, laboratory services and care for vulnerable populations.

Many civil society organisations and specialised clinics have already experienced funding reductions following earlier cuts to U.S. foreign assistance. Public health experts warn that additional reductions could disproportionately affect prevention programmes targeting key populations, including adolescents, sex workers and LGBTQ+ communities.

While antiretroviral treatment is expected to continue through South Africa's national health system, support services may become increasingly difficult to sustain.

PEPFAR's Legacy in Global Health

PEPFAR is widely regarded as one of the most successful international health initiatives ever established. Beyond providing HIV treatment, the programme has strengthened healthcare systems by investing in laboratory infrastructure, disease surveillance, healthcare worker training and maternal and child health services.

Many of these capacities later proved invaluable during outbreaks such as Ebola and the COVID-19 pandemic, demonstrating that investments in HIV programmes often benefit broader public health systems.

The potential withdrawal of funding therefore raises concerns extending well beyond HIV care alone.

Implications for Global Health Partnerships

The decision comes at a time when many international health programmes are facing financial uncertainty. Several global organisations have warned that reductions in donor funding could slow progress towards ending HIV as a public health threat by 2030, one of the Sustainable Development Goals.

The South African case also illustrates the growing interaction between global health financing and international geopolitics. Increasingly, development assistance is influenced not only by health priorities but also by broader diplomatic and economic considerations.

For recipient countries, this may reinforce the importance of strengthening domestic financing and building more resilient health systems capable of adapting to changes in international support.

Looking Ahead

South African health authorities have stated that they remain committed to maintaining essential HIV services, although many experts expect the transition away from U.S. funding to present significant operational and financial challenges.

As discussions continue, healthcare providers, international organisations and civil society groups are calling for coordinated strategies to minimise disruptions to prevention, treatment and patient care.

Read the full article here.

Further Links